Cambrex is a small molecule company headquartered in East Rutherford, New Jersey, specializing in the research, development, and manufacture of small molecule therapeutics. Established in 1981, Cambrex offers a comprehensive range of services, including drug substance, drug product, and analytical services, catering to the pharmaceutical industry. The company possesses advanced technologies and capabilities such as biocatalysis, continuous flow processes, and solid-state science, alongside conventional dosage forms like oral solids, semi-solids, and liquids. Cambrex also produces specialized dosage forms, including modified-release and fixed-dose combination products, to support pharmaceutical companies in accelerating their drug development processes. With a dedicated team of experts, Cambrex is recognized for its reliability in both branded and generic markets.
Avista Pharma Solutions is a contract testing, development, and manufacturing organization that provides essential services to clients in the pharmaceutical, animal health, and medical device sectors. With over 200,000 square feet of laboratory and manufacturing space across locations in Agawam, MA, Durham, NC, and Longmont, CO, the company specializes in a comprehensive range of scientifically differentiated offerings. These services include early-stage drug development, active pharmaceutical ingredient (API) and drug product development, as well as cGMP manufacturing. Additionally, Avista Pharma provides stand-alone analytical and microbiology testing support, positioning itself as a valuable partner in the creation and production of new medicinal drugs.
Halo Pharmaceutical, located in Whippany, New Jersey, specializes in contract dosage form development, manufacturing, and testing services for the pharmaceutical, biotechnology, and generic sectors. The company provides a comprehensive range of services that include the development and production of various dosage forms, such as tablets, capsules, powders, liquids, creams, and both sterile and nonsterile ointments and suppositories. By focusing on integrated capabilities, Halo Pharmaceutical aims to support its clients in advancing their products and ultimately improving patient outcomes.
PharmaCore is a prominent partner in small molecule drug discovery, development, and manufacturing for pharmaceutical and biotechnology companies. The company provides a comprehensive range of services that align with the drug discovery process, offering advantages from lead discovery to lead optimization, chemical synthesis, and scale-up of pharmaceutical intermediates. PharmaCore excels in custom organic synthesis and produces active pharmaceutical ingredients using various chemistries. With GMP manufacturing facilities capable of scaling from grams to multi-kilogram quantities, the company operates eight GMP production areas equipped with reactors up to 2000 liters. PharmaCore's experienced Quality Assurance team ensures compliance with FDA and international regulations, while its state-of-the-art analytical services laboratories offer extensive testing capabilities and methods development. The company is also licensed to manufacture controlled substances and has expertise in logistics management for these regulated materials. Many clients leverage PharmaCore's skilled scientists as an extension of their own chemistry teams through both short and long-term contract research programs.
Xcellsyz
Acquisition in 2006
Xcellsyz is a biotechnology company, focusses on the discovery of new drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.